两连板申联生物：艾滋病单克隆抗体等创新药管线由联营公司独立运营

Group 1 - The company, Shenlian Bio, has issued a notice regarding its business operations, which primarily focus on veterinary biological products [2] - The innovative drug pipeline, including monoclonal antibodies for HIV, is independently operated by its joint venture, Yangzhou Shizhiyuan Biotechnology Co., Ltd [2] - The related business is characterized by long research and development cycles, significant investment, and high research risks [2]